Vericel (VCEL) Total Debt (2010 - 2018)
Vericel's (VCEL) quarterly Total Debt came in at $13.2 million in Q3 2018, up 52.07% year-on-year from $8.7 million in Q3 2017, and down 23.64% quarter-over-quarter from $17.3 million in Q2 2018.
Vericel (VCEL) Total Debt (2010 - 2018) Analysis & Trends
Vericel has disclosed Total Debt across 9 years of filings, most recently posting $13.2 million for Q3 2018.
- Total Debt for Q3 2018 came in at $13.2 million, up 52.07% year-over-year; the trailing twelve-month figure through Sep 2018 was $13.2 million (up 52.07% YoY), and the FY2017 annual result was $17.9 million, up 2107.4% from the prior year.
- Total Debt came in at $13.2 million for Q3 2018 at Vericel, down from $17.3 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $17.9 million in Q4 2017 to a low of $2000.0 in Q1 2014.
- The 5-year median for Total Debt is $700000.0 (2016), against an average of $5.1 million.
- Across the five-year window, Total Debt sank 96.36% in 2015 and surged 16230.65% in 2017, its largest moves.
- Vericel's Total Debt stood at $457000.0 in 2014, then tumbled by 84.46% to $71000.0 in 2015, then soared by 1042.25% to $811000.0 in 2016, then jumped by 2107.4% to $17.9 million in 2017, then retreated by 26.36% to $13.2 million in 2018.
- The last three Total Debt figures came in at $13.2 million (Q3 2018), $17.3 million (Q2 2018), and $17.2 million (Q1 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 13.18 Mn |
| Jun 30, 2018 | 17.26 Mn |
| Mar 31, 2018 | 17.25 Mn |
| Dec 31, 2017 | 17.90 Mn |
| Sep 30, 2017 | 8.67 Mn |
| Jun 30, 2017 | 8.25 Mn |
| Mar 31, 2017 | 10.13 Mn |
| Dec 31, 2016 | 811,000.00 |
| Sep 30, 2016 | 700,000.00 |
| Jun 30, 2016 | 52,000.00 |
| Mar 31, 2016 | 62,000.00 |
| Dec 31, 2015 | 71,000.00 |
| Sep 30, 2015 | 81,000.00 |
| Jun 30, 2015 | 91,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 457,000.00 |
| Sep 30, 2014 | 153,000.00 |
| Jun 30, 2014 | 2.50 Mn |
| Mar 31, 2014 | 2,000.00 |
| Dec 31, 2013 | 6,000.00 |